Stretching DNA in nanochannels is a useful tool for direct, visual studies of genomic DNA at the single molecule level. To facilitate the study of the interaction of linear DNA with proteins in nanochannels, we have implemented a highly effective passivation scheme based on lipid bilayers. We demonstrate virtually complete long-term passivation of nanochannel surfaces to a range of relevant reagents, including streptavidin-coated quantum dots, RecA proteins, and RecA-DNA complexes. We show that the performance of the lipid bilayer is significantly better than that of standard bovine serum albumin-based passivation. Finally, we show how the passivated devices allow us to monitor single DNA cleavage events during enzymatic degradation by DNase I. We expect that our approach will open up for detailed, systematic studies of a wide range of protein-DNA interactions with high spatial and temporal resolution.
Stretching DNA in nanochannels is a useful tool for direct, visual studies of genomic DNA at the single molecule level. To facilitate the study of the interaction of linear DNA with proteins in nanochannels, we have implemented a highly effective passivation scheme based on lipid bilayers. We demonstrate virtually complete long-term passivation of nanochannel surfaces to a range of relevant reagents, including streptavidin-coated quantum dots, RecA proteins, and RecA-DNA complexes. We show that the performance of the lipid bilayer is significantly better than that of standard bovine serum albumin-based passivation. Finally, we show how the passivated devices allow us to monitor single DNA cleavage events during enzymatic degradation by DNase I. We expect that our approach will open up for detailed, systematic studies of a wide range of protein-DNA interactions with high spatial and temporal resolution.
Single-molecule studies of biomolecules
and biomolecular interactions have attracted strong interest due to
the additional (e.g., mechanistic) information that can be gained
when ensemble averaging is avoided.[1] One
promising tool for these types of studies is the nanofluidic chip,
where macromolecules, such as DNA, can be stretched, directly visualized,
manipulated, and probed on their own length scales without being constrained
by tethering to beads or surfaces.[2] Nanofluidic
channels have been used both to understand the polymer physics of
confined DNA[3] and for DNA mapping.[4] While some proof-of-principle experiments of
DNA–protein interactions in nanochannels have been performed,[2c,2d] widespread use remains elusive due to the problem of nonspecific
adhesion of the proteins to channel walls, which is exacerbated by
the extreme surface-to-volume ratio in nanofluidics. This problem
becomes especially serious when the molecular constituents have opposite
charge, as is the case for the interaction of DNA with many types
of DNA-binding proteins. While DNA is a polyanion and is thus repelled
from the negatively charged materials (such as SiO2) typically
used in nanofluidic structures, DNA-binding proteins are generally
positively charged and/or hydrophobic and will therefore tend to stick
to the channel walls. The standard means for passivating surfaces
for protein studies include saturating the surface with either bovine
serum albumin (BSA)[5] or caseins (from dry
milk powder) or coating the surface with PLL-g-PEG.[6] Although such methods have proven very useful for open
surfaces and in microfluidics, they have limited applicability to
nanofluidics since, relying on stochastic binding to the surface and/or
competition with the sample of interest, they are prone to defects.
Furthermore, the passivation agent is often charged so that it can
stick to the surfaces, but this limits its usefulness for studies
of interactions between oppositely charged molecules in nanofluidic
systems. For these reasons we see a compelling need for novel approaches
to passivate nanofluidics structures. In order to maintain uniformity
of the channel dimensions and to avoid clogging, there are two main
factors to keep in mind when designing such a passivation scheme.
First, as the size of the device structures approaches molecular dimensions,
the smoothness of the passivation layer is increasingly important.
Second, again due to the extremely small dimensions of nanofluidic
channels, it is important to minimize the amount of impurities and
debris in the channels.In almost all living organisms a lipid
bilayer (LBL) forms the
basis of the cellular structures due to its ability to suppress any
kind of nonspecific binding and protein fouling while efficiently
accommodating specific binding of membrane proteins.[7] For the case of microfluidics, the formation and physical
properties of spreading LBLs have been studied extensively during
the past years.[8] In particular, it has
been demonstrated how supported LBLs can be formed and manipulated
in microfluidic channels using electrophoresis and shear flows.[9] Furthermore, many applications explore the possibility
to vary the overall charge of the LBL[10] and to insert specific chemical functionalities, such as biotin
or DNA oligonucleotides, into the LBL, thereby providing a more versatile
surface.[11]In this study we demonstrate
the use of LBLs as a passivation layer
in nanofluidic networks, consisting of nanochannels and nanoslits,
fabricated in fused silica. As opposed to immobilization-based passivation
schemes, the use of LBLs provides a fluid, self-healing layer that
is extremely smooth and inert to a wide variety of biomolecules. We
investigate the properties of the formed LBL using fluorescence microscopy
and demonstrate its ability to prevent sticking of protein-coated
quantum dots and DNA–protein complexes.
Results and Discussion
To form a LBL in nanochannels
of dimensions on the order of 100 nm, we first deposited lipid vesicles
in the microchannels, allowed them to rupture, and then let the formed
LBL spontaneously spread into the nanostructures (Figure 1a). We thus formed a uniform LBL in the nanochannels without
introducing any vesicles into the channels. By imposing a counter
flow of buffer (∼80 μm/s) opposite to the direction of
the LBL spreading (see Supporting Information), we ensured that no lipid vesicles or debris entered into the nanochannels
during the formation of the LBL. This approach was used for all data
presented in this work with the exception of that presented in Figure 2a where the flow was in the direction of the LBL
propagation in order to enable a partially lipid-covered surface.
The spreading of the LBL front was characterized by fitting a power
law to the progression of the LBL (Figure 1b; see Supporting Information) and was
found to be consistent with surface-energy driven lipid spreading.[8]
Figure 1
Lipid passivation of micro- and nanochannels. (a) Schematic
overview
of the device. Four microchannels
are used to bring in reagents to the nanofluidic structures in the
center. In the illustrated scenario the right microchannel contains
lipid vesicles and is coated with a LBL that spreads against a fluid
flow into the nanochannels and the slit. (b) Progression of the LBL
in a nanochannel array. Solid line: averaged position of the progressing
front of the LBLs in 90 nanochannels (150 × 110 nm2), as shown in the images. Dashed line: power-law fit to the experimental
data. The three images are recorded at times indicated by the arrows
along the axis. (c) FRAP demonstrates the fluidity of the LBL in the
nanochannels. Solid line: time dependence of the fluorescence of the
center of a photobleached spot (10 μm radius) in an array of
150 × 110 nm2 nanochannels, coated with a fluorescent
LBL. The four images are recorded at times indicated by the arrows
along the axis.
Figure 2
(a) Fluorescence micrograph of a nanoslit
in the center and arrays
of nanochannels in the upper and lower right-hand side corners (see
the schematic in the inset) partially coated with a LBL (red). Note
that in this case, in order to enable the patterning of the LBL, the
LBL was introduced with the flow of the vesicles. Bright green spots,
corresponding to bound streptavidin-QDs, clearly indicate the propensity
of nonspecific binding to the uncoated areas and, by contrast, show
that the number of defects in the LBL is very low. (b) Fluorescence
micrograph of streptavidin-QDs (green) in an array of BSA-coated nanochannels.
(c) Fluorescence micrograph of streptavidin-QDs (green) in an array
of LBL-coated nanochannels (red). The slit in (a) is 150 nm deep.
The cross-sectional dimensions of the nanochannels are (a) 150 ×
120 nm2 and (b) and (c) 100 × 150 nm2.
The nanostructures have been flushed with a streptavidin-QD solution
and subsequently thoroughly washed with buffer.
To confirm the fluidity and continuity
of the LBLs that are formed, we characterized the lipid coating using
fluorescence recovery after photobleaching (FRAP)[10] (see Supporting Information).
After photobleaching, the fluoroescence in the bleached area recovers
fully in approximately 1 h due to the replacement of the bleached
molecules by an influx of molecules from areas that were not exposed
to light; Figure 1c shows how the bilayer,
as expected, recovers along the nanochannels only. A rough estimate
of the lipid diffusion coefficient is D ≈
1 μm2/s (see Supporting Information), which is in good agreement with previously reported values (1.42
μm2/s) for DHPE-rhodamine in POPC bilayers.[12]Lipid passivation of micro- and nanochannels. (a) Schematic
overview
of the device. Four microchannels
are used to bring in reagents to the nanofluidic structures in the
center. In the illustrated scenario the right microchannel contains
lipid vesicles and is coated with a LBL that spreads against a fluid
flow into the nanochannels and the slit. (b) Progression of the LBL
in a nanochannel array. Solid line: averaged position of the progressing
front of the LBLs in 90 nanochannels (150 × 110 nm2), as shown in the images. Dashed line: power-law fit to the experimental
data. The three images are recorded at times indicated by the arrows
along the axis. (c) FRAP demonstrates the fluidity of the LBL in the
nanochannels. Solid line: time dependence of the fluorescence of the
center of a photobleached spot (10 μm radius) in an array of
150 × 110 nm2 nanochannels, coated with a fluorescent
LBL. The four images are recorded at times indicated by the arrows
along the axis.To evaluate the usefulness of LBLs as a passivation
coating, we
introduce three types of samples into our devices: streptavidin-coated
quantum dots (streptavidin-QDs), fluorescently labeled RecA proteins
and RecA–DNA complexes. Bright streptavidin-QDs allowed us
to evaluate any deficiencies in the ability of LBLs to prevent nonspecific
protein binding, for example, due to small voids in the bilayer. Streptavidin-QDs
were used because they provide a clear fluorescence signal for the
presence of the streptavidin and because they are commonly used for
labeling various types of biomolecules. The streptavidin molecules
thus addressed the passivation capabilities of the LBL, while the
bright fluorescence from the QDs pinpointed where any defects were
located. The streptavidin-QDs were introduced into a nanofluidic chip
consisting of a nanoslit (horizontal) and several nanochannels (vertical),
both partially coated with a LBL (Figure 2a).
The channels were flushed with streptavidin-QDs and subsequently with
buffer. While the streptavidin-QDs to a large extent stick to the
noncoated part, there is almost no sticking to the LBL-coated part
of the nanostructure. Sporadic streptavidin-QD binding can be seen,
but binding to the few available defect sites saturates quickly and
at low concentrations, which indicates that the streptavidin-QDs are
bound to static defects in the LBL. Freely diffusing streptavidin-QDs
were also observed in the LBL-coated structures in the absence of
flow (see Supporting Information), demonstrating
the effectiveness of the LBL coating.To compare the performance
of the LBL passivation to that of standard
passivation schemes, we characterized the sticking properties of streptavidin-QDs
in nanochannels prepared according to standard protocols with BSA.[5] BSA is a routine passivation agent in microfluidics
and has been used in studies of DNA–protein interactions in
nanochannels.[2c,2d] In Figure 2b,c the results of passivation of nanochannels with BSA and LBL,
respectively, are compared. For the BSA-coated nanochannels (for details
on the coating see Experimental Section and Supporting Information) streptavidin-QDs can
be readily flushed into the chip, but a significant number of them
remain stuck to the channel walls (more than 400 streptavidin-QD per
100 μm2, Figure 2b) even after
thorough washing with buffer. In contrast, coating the nanochannels
with a LBL leads to a significantly lower density of stuck streptavidin-QDs
(less than 1 streptavidin-QD per 100 μm2, Figure 2c) after washing. The corresponding number for uncoated
channels, determined from Figure 2a, is on
the order of 104 streptavidin-QDs per 100 μm2, which completely blocks the nanochannels. We would like
to emphasize that while the LBL spreads as a single entity and relies
on the formation of a LBL in the microchannels, the
BSA coating relies on single monomers entering the nanochannels and
binding randomly to the surface, which in turn leads to a more uneven
coating with more defects, as demonstrated by our streptavidin-QD
experiments. In the experiments above, the relative performance of
the LBL-coated nanostructures is underestimated since they allow a
more concentrated flux of streptavidin-QDs than both the BSA-coated
channels and the noncoated channels.(a) Fluorescence micrograph of a nanoslit
in the center and arrays
of nanochannels in the upper and lower right-hand side corners (see
the schematic in the inset) partially coated with a LBL (red). Note
that in this case, in order to enable the patterning of the LBL, the
LBL was introduced with the flow of the vesicles. Bright green spots,
corresponding to bound streptavidin-QDs, clearly indicate the propensity
of nonspecific binding to the uncoated areas and, by contrast, show
that the number of defects in the LBL is very low. (b) Fluorescence
micrograph of streptavidin-QDs (green) in an array of BSA-coated nanochannels.
(c) Fluorescence micrograph of streptavidin-QDs (green) in an array
of LBL-coated nanochannels (red). The slit in (a) is 150 nm deep.
The cross-sectional dimensions of the nanochannels are (a) 150 ×
120 nm2 and (b) and (c) 100 × 150 nm2.
The nanostructures have been flushed with a streptavidin-QD solution
and subsequently thoroughly washed with buffer.Lipid-coated nanochannels are potentially a powerful
tool to directly
visualize the organization and the dynamics of protein–DNA
complexes. A key requirement for these types of experiments is that
the DNA can move freely in the channels. Therefore, we first rule
out any obstructions in the nanochannels or any nonspecific sticking
of the DNA to the lipids by introducing fluorescently stained λ-phage
DNA into the nanochannels (see movie in Supporting
Information). To demonstrate the antifouling properties of
the LBL, we introduce a solution containing fluorescently labeled
RecA proteins and nonstained λ-phage DNA into the chip (Figure 3). RecA is a prokaryotic enzyme that catalyzes DNA
strand-exchange reactions during homologous recombination and has
a role in stimulating DNA repair.[13] RecA
forms filaments on DNA that can be several micrometers long. RecA
proteins that are not DNA bound are small, and diffuse fast in the
microchannels, reaching the nanochannels first. Flushing
the proteins through the nanochannels, starting in the LBL-coated
end, reveals that while the proteins do not stick to the LBL-coated
part, the untreated nanochannels light up quickly due to adsorption
of the fluorescently tagged protein (Figure 3B). Subsequently, large RecA–DNA complexes can be seen to
readily move in the lipid-coated nanochannels while they stick immediately
upon contact with the untreated nanochannel (Figure 3C).
Figure 3
Lipid bilayer prevents sticking of RecA protein in nanochannel
(400 × 150 nm2) arrays. (a) LBLs, labeled with rhodamine-DHPE,
coating the right-hand half of the channels, observed at 540 nm excitation
wavelength. (b) RecA proteins, observed at a 475 nm excitation wavelength,
are flushed through the device and absorbed where there is no LBL.
Note that (a) and (b) are recorded at the exact same location on the
chip. (c) RecA bound to DNA approaching from the right in lipid-bilayer
treated channels toward the untreated channels. The untreated channels
are clearly visible to the left with their nonspecifically bound fluorescently
stained RecA proteins. Arrows indicate the direction of the fluid
flow driving the motion of the DNA. The RecA–DNA complex is
immediately bound once it makes contact to the untreated channels.
Lipid bilayer prevents sticking of RecA protein in nanochannel
(400 × 150 nm2) arrays. (a) LBLs, labeled with rhodamine-DHPE,
coating the right-hand half of the channels, observed at 540 nm excitation
wavelength. (b) RecA proteins, observed at a 475 nm excitation wavelength,
are flushed through the device and absorbed where there is no LBL.
Note that (a) and (b) are recorded at the exact same location on the
chip. (c) RecA bound to DNA approaching from the right in lipid-bilayer
treated channels toward the untreated channels. The untreated channels
are clearly visible to the left with their nonspecifically bound fluorescently
stained RecA proteins. Arrows indicate the direction of the fluid
flow driving the motion of the DNA. The RecA–DNA complex is
immediately bound once it makes contact to the untreated channels.As an example of a dynamic process that we can
observe in our devices,
we demonstrate the activity of a working enzyme in the nanochannels
by introducing λ-phage DNA in LBL-passivated nanochannels together
with DNase I,[14] an enzyme that cuts DNA
at random locations. To be able to observe the actual cutting of the
DNA, we introduced the DNA and the enzyme separately at different
ends of the nanochannels. The DNA encounters the enzyme within the
nanochannel, and because of the low concentration of the enzyme, individual
cutting events are observed (Figure 4a,b).
The DNA is typically entirely degraded within a time span of ∼10
s. This corresponds to the expected diffusion time of the enzyme along
the length of the λ-phage DNA in the channel, consistent with
the known fast reaction kinetics of DNase I.[14] As a negative control we rule out any significant contribution of
photonicking to the degradation of the DNA by a comparison with DNA
in nanochannels without enzyme (Figure 4c).
Here the DNA remains intact over a ∼5 min time scale.
Figure 4
Kymographs
of DNA in nanochannels. (a,b) Two examples of λ-phage
DNA in a nanochannel encountering DNase I enzymes. Single cuts are
clearly visible. (c) λ-phage DNA in a lipid-coated nanochannel
without DNase I.
Kymographs
of DNA in nanochannels. (a,b) Two examples of λ-phage
DNA in a nanochannel encountering DNase I enzymes. Single cuts are
clearly visible. (c) λ-phage DNA in a lipid-coated nanochannel
without DNase I.The process of forming the LBL and the LBL itself
is very robust.
The LBL can withstand shear rates that significantly exceed what is
typically relevant for DNA-related applications, as evidenced by the
counter flow rates used during the LBL coating in our experiments
(with shear rates at the surface ∼6 × 103 s–1) and as reported in the literature on the shear-induced
motion of LBLs (with shear rates at the surface ∼3 × 104 s–1).[9a] The
LBL-coated channels can be left in buffer for at least a week, without
loosing the antifouling properties. Furthermore, we performed at least
five cycles of removal of the LBL using SDS followed by formation
of a LBL in the same chip without any detectable change in performance
nor in FRAP behavior. Another important feature of the LBL coated
chip is that the LBL is compatible with a wide range of buffers necessary
for a diverse set of experimental requirements. The three different
applications demonstrated above were all done in different buffers,
and none was performed in the buffer used for coating. We also note
that the use of a LBL coating will allow us to insert specific groups
with a variety of chemistries into the nanochannels or make it possible
to tailor the surface charge of the channels by changing the composition
of the lipid mixture.In conclusion, we have demonstrated the
performance of a LBL coating
as an excellent passivation approach for nanofluidics in a range of
applications. We have demonstrated that a LBL prevents sticking of
streptavidin-QDs and RecA proteins to the walls of a nanofluidic device.
We have further shown that the LBL passivation allows us to visualize
RecA–DNA complexes as well as enzymatic digestion by DNase
I along stretched DNA molecules in the nanochannels. We envision that
the LBL passivation approach will be useful for systematic elucidation
of kinetics and site specificity of protein–DNA interactions
as well as for implementing DNA sequencing.
Experimental Section
Nanofluidic Devices
The devices were made using standard
micro and nanofabrication techniques as described in detail elsewhere.[2a] An overview of the device design is given in
the Supporting Information (Figure S1).
The device fabrication comprises electron beam lithography for the
definition of the nanochannels (with periodicity of 1 μm and
channel widths ranging from 100 to 400 nm and depths 100 to 150 nm)
and nanoslits of 150 nm depth, UV lithography for the definition of
the microchannels (with typical widths of 50 μm and depths of
1 μm), and reactive-ion etching to make the channels in a fused-silica
substrate. The dimensions of the channels were measured using electron
microscopy and profilometry before sealing. After drilling holes in
the substrates using sand blasting for sample access, the devices
were sealed using thermal fusion bonding. The devices were mounted
in a chuck and wetted as previously described.[2a]
Lipids
For the creation of LBLs we used zwitterionic
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) lipids with 1% lissamine rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt
(rhodamine-DHPE) lipids added to enable observation of the LBL formation
with fluorescence microscopy. Prior to each coating procedure, lipid
vesicles of approximately 70 nm diameter were created by extrusion
(see Supporting Information). The extruded
vesicle solution was flushed through one of the microchannels of the
fluidic system. Subsequently, the lipid vesicles settle down on the
surface, rupture, and form patches of LBL that connect within a few
minutes to a continuous LBL, coating the entire microchannel. The
LBL is subsequently allowed to spread spontaneously into the nanochannels,
while the flow of lipid vesicles is sustained in the coated microchannel
to ensure a steady supply of vesicles. During the coating process,
a counter flow (∼80 μm/s) through the nanochannels is
imposed into the coated microchannel to avoid any debris or vesicles
in the nanochannels. This approach was used for all data described
in the work except for that presented in Figure 2a where an alternative, slightly quicker method was used. Here we
flush the lipid vesicles from the LBL-coated microchannels into the
nanochannels where they are allowed to deposit and rupture. However,
with this method vesicles and other residues may deposit, potentially
blocking the nanochannels. See the Supporting
Information for movies illustrating the two approaches.
Imaging
For all the imaging presented here a Nikon
TE-2000 inverted fluorescence microscope equipped with a 100W mercury
lamp, a 60× NA 1.00 water immersion objective (Nikon), and an
Andor iXon EMCCD camera (DV-897) was used.
Streptavidin-QD Experiments
Streptavidin-QDs (Qdot
585), purchased from Molecular Probes (Life Technologies), were introduced
in the nanofluidic network at a concentration of 0.17 μM. The
buffer used was 100 mM NaCl, 10 mM Tris, 10 mM boric acid, and 0.225
mM EDTA (pH 8.0).
BSA Experiments
BSA with a dye–protein ratio
of 5:1 (Alexa Fluor 488 conjugate), purchased from Molecular Probes
(Life Technologies), was introduced in 100 × 150 nm2 nanochannels. To ensure saturation of the surfaces, the BSA concentration
used was 800 μg/mL buffer (100 mM NaCl, 10 mM Tris, 10 mM boric
acid, and 0.225 mM EDTA, pH 8.0).[5] The
protein solution remained inside the nanochannels for 12 h before
the nanofluidic system was rinsed with buffer, and streptavidin-QDs
were introduced and subsequently washed out.
RecA/RecA–DNA Experiments
λ-phage DNA,
purchased from New England Bio Laboratories (NEB), and fluorescently
labeled RecA were mixed in a test tube to concentrations of 0.8 μM
base pairs (0.5 μg/mL) and 1 μM, respectively. The buffer
used was 3.75× TBE with 50 μM ATP-γS and 2 mM Mg2+. Subsequently, the solution was introduced into the nanofluidic
system. Recombinant RecA was produced and labeled with ATTO 488-NHS
ester at pH 6.2, as described in ref (15), and stored in 300 mM KCl, 20 mM Tris-HCl pH
7.5, 0.5 mM EDTA, 1 mM DTT, and 10% glycerol at −80 °C.
DNase I Experiments
DNase I, purchased from Sigma-Aldrich,
was introduced on one side of the nanochannels at a concentration
of 0.12 units/μL in 1.2× reaction buffer. λ-phage
DNA, purchased from New England BioLabs (NEB), was introduced from
the opposite end of the nanochannels. Subsequently, the flow was stopped,
and the DNase I was allowed to diffuse into the nanochannels and reach
the confined DNA molecules. We used a DNA solution at 0.5 μg/mL
in 0.05× TBE buffer with 5 mM NaCl, containing 3% 2-mercaptoethanol
(BME).
Authors: Jonas O Tegenfeldt; Christelle Prinz; Han Cao; Steven Chou; Walter W Reisner; Robert Riehn; Yan Mei Wang; Edward C Cox; James C Sturm; Pascal Silberzan; Robert H Austin Journal: Proc Natl Acad Sci U S A Date: 2004-07-13 Impact factor: 11.205
Authors: Walter Reisner; Niels B Larsen; Asli Silahtaroglu; Anders Kristensen; Niels Tommerup; Jonas O Tegenfeldt; Henrik Flyvbjerg Journal: Proc Natl Acad Sci U S A Date: 2010-07-07 Impact factor: 11.205
Authors: Anthony L Forget; Christopher C Dombrowski; Ichiro Amitani; Stephen C Kowalczykowski Journal: Nat Protoc Date: 2013-02-14 Impact factor: 13.491
Authors: Yu Wang; Rachel D Lowe; Yara X Mejia; Holger Feindt; Siegfried Steltenkamp; Thomas P Burg Journal: Biomicrofluidics Date: 2013-04-22 Impact factor: 2.800
Authors: E Werner; A Jain; A Muralidhar; K Frykholm; T St Clere Smithe; J Fritzsche; F Westerlund; K D Dorfman; B Mehlig Journal: Biomicrofluidics Date: 2018-03-09 Impact factor: 2.800
Authors: Andreas Schmitt; Kai Jiang; Martha I Camacho; Venkateswara Rao Jonna; Anders Hofer; Fredrik Westerlund; Peter J Christie; Ronnie P-A Berntsson Journal: Mol Microbiol Date: 2018-07-31 Impact factor: 3.501
Authors: Ignacio F Gallardo; Praveenkumar Pasupathy; Maxwell Brown; Carol M Manhart; Dean P Neikirk; Eric Alani; Ilya J Finkelstein Journal: Langmuir Date: 2015-09-08 Impact factor: 3.882
Authors: Karolin Frykholm; Ronnie Per-Arne Berntsson; Magnus Claesson; Laura de Battice; Richard Odegrip; Pål Stenmark; Fredrik Westerlund Journal: Nucleic Acids Res Date: 2016-04-29 Impact factor: 16.971